logo
Lazard Releases 2025 Levelized Cost of Energy+ Report

Lazard Releases 2025 Levelized Cost of Energy+ Report

Business Wire16-06-2025
NEW YORK--(BUSINESS WIRE)--Lazard Inc. (NYSE: LAZ) is proud to announce the release of the 18 th edition of its Levelized Cost of Energy+ (LCOE+) report, a widely-cited, annual analysis that provides insights into the cost competitiveness of various energy generation technologies. The report explores key aspects of energy generation, energy storage, and system-level considerations while reflecting on developments over the past 12 months.
'In today's rapidly evolving energy landscape, the relevance of data-driven decision-making has never been more critical and the LCOE+ serves as an invaluable resource for industry stakeholders, policymakers, and investors,' said George Bilicic, Vice Chairman of Investment Banking and Global Head of Power, Energy & Infrastructure, Lazard.
Key Findings from the 2025 LCOE+ Report
Renewables Remain Competitive: Unsubsidized Wind & Solar Lowest Cost Generation Sources for Last 10 Years
Despite facing macro challenges and headwinds, utility-scale solar and onshore wind remain the most cost-effective forms of new-build energy generation on an unsubsidized basis (i.e., without tax subsidies). As such, renewable energy will continue to play a key role in the buildout of new power generation in the U.S. as the lowest-cost and quickest-to-deploy generation.
Increased Cost of Gas-Fired Generation: Gas-Fired Generation Reaches 10-Year High LCOE
While persistent low gas prices, high energy demand and increasing renewable LCOEs have resulted in the continued cost competitiveness of operating existing baseload gas generation, the cost of building a new combined cycle gas turbine has reached a 10-year high. Turbine shortages, rising costs and long delivery times are expected to continue driving steep LCOE increases for gas technologies in the near term—however, productivity enhancements and supply chain normalization could offset such increases over the longer term.
Storage Cost Decline: Significant YOY Declines Offset 2021 – 2024 Increases, Dropping LCOE to 2020 Level
This year's report shows sharp declines for battery energy storage systems across hybrid and standalone storage projects. Key drivers of such results include both market dynamics (e.g., lower-than-expected EV demand and the resulting oversupply of cells) and technological advancements (e.g., increased cell capacity and energy density).
System Analysis is Evolving: More Renewables Requires More Sophisticated Capacity Accreditation
As renewable penetration increases, several independent system operators are refining their capacity accreditation methodologies to incorporate seasonal adjustments and diversity benefits, which have generally driven up firming costs. The continued development of more sophisticated capacity accreditation frameworks could have significant impacts on future firming costs.
The recent transformation of the energy sector has not been without challenges, including technological limitations, transmission and distribution infrastructure investment impediments, regulatory and geopolitical considerations, capital scarcity and, arguably most fundamentally, increasing recent power demand.
These challenges have become more prominent as renewable energy has gone from a nascent 'emerging' technology to an Industry, accounting for more than 20 percent of the U.S. electricity system, with 'supermajors' of its own. With this growth, debates over energy technology development, mix, costs, environmental impacts and policies have become increasingly relevant and complex. Lazard takes pride in publishing the LCOE+ as a snapshot in time based on real-world, U.S. project data, rather than a prediction of the future and as work product to contribute to the ongoing dialogue.
To download the full 2025 Levelized Cost of Energy+ report, click here.
About Lazard
Founded in 1848, Lazard is the preeminent financial advisory and asset management firm, with operations in North and South America, Europe, the Middle East, Asia, and Australia. Lazard provides advice on mergers and acquisitions, capital markets and capital solutions, restructuring and liability management, geopolitics, and other strategic matters, as well as asset management and investment solutions to institutions, corporations, governments, partnerships, family offices, and high net worth individuals. For more information, please visit Lazard.com and follow Lazard on LinkedIn.
LAZ-CPE
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

DA Davidson Lifts Salesforce (CRM) to Neutral, Keeps $225 PT
DA Davidson Lifts Salesforce (CRM) to Neutral, Keeps $225 PT

Yahoo

timea minute ago

  • Yahoo

DA Davidson Lifts Salesforce (CRM) to Neutral, Keeps $225 PT

Salesforce, Inc. (NYSE:CRM) is one of the . On August 15, DA Davidson upgraded the stock to Neutral from Underperform with an unchanged price target of $225. According to the firm, declining investor sentiment is appropriate for a business whose organic growth in its core is decelerating along with mounting competitive pressure. However, Starboard has increased its stake in Salesforce by 47% this quarter and 'another round of activist involvement may help the company correct course.' A professional trader working on a laptop in a busy stock exchange. Upgrading the stock, the firm said the 'challenges' are already priced in for Salesforce. 'We are upgrading our rating to NEUTRAL from Underperform and maintaining our $225 price target based on 18.5x our updated FY27 EPS estimate.' Salesforce, Inc. (NYSE:CRM) is a cloud-based CRM company that has gained popularity after it unveiled its AI-powered platform called Agentforce. While we acknowledge the potential of CRM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Bernstein Reaffirms Outperform on TSM, $249 PT Amid Rising Capex Trends
Bernstein Reaffirms Outperform on TSM, $249 PT Amid Rising Capex Trends

Yahoo

timea minute ago

  • Yahoo

Bernstein Reaffirms Outperform on TSM, $249 PT Amid Rising Capex Trends

Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) is one of the On August 15, Bernstein SocGen Group analyst Mark Li reiterated an Outperform rating on the stock with a $249.00 price target. The firm's analysis is a reflection of TSMC's significant position in the semiconductor equipment market. Investors are paying close attention to TSM's spending plans as they impact semiconductor equipment stocks, the broader chip industry, and AI. Bernstein noted that a substantial portion of TSMC's capital expenditure is allocated to infrastructure and non-wafer-based equipment, such as packaging and testing technologies. The firm also noted how WFE-to-semiconductor ratio remains elevated due to on shoring trends and technological complexity. Recent data illustrates that capital expenditure per wafer is also rising more rapidly than previously anticipated. Moreover, TSMC's spending is deflationary while China's is inflationary. With the US pushing companies to bring production back home, it is unclear whether it will be as aggressive as China. 'TSMC is 15-25% of the global wafer fab equipment (WFE) market, but China is 30-40%, as a sizable part of TSMCs capex is for infrastructure & non-wafer-based equipment (e.g. for packaging & testing). 15-25% is consistent with TSMC being10-20% of their total revenue disclosed by AMAT & TEL & 30-40% by ASML. Technology complexity & onshoring trend will keep the overall WFE/semi ratio elevated if not higher. Recent data suggests capex per wafer is rising more rapidly than we thought. More importantly TSMCs deflationary but China is inflationary & much bigger. The US uses tariffs, etc. to push onshoring capacity but also grants exemptions. This motivates companies/countries to over-promise & under-deliver. Time will tell if the US will be as forceful as China to make the US as meaningful to WFE.' Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) manufactures and sells advanced chips used in artificial intelligence applications. While we acknowledge the potential of TSM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None.

Berkshire's UnitedHealth Bet Highlights Long-Term Confidence Despite Depressed Earnings
Berkshire's UnitedHealth Bet Highlights Long-Term Confidence Despite Depressed Earnings

Yahoo

timea minute ago

  • Yahoo

Berkshire's UnitedHealth Bet Highlights Long-Term Confidence Despite Depressed Earnings

On Friday, high-profile investors Michael Burry and Warren Buffett took positions in UnitedHealth Group Inc. (NYSE:UNH). Warren Buffett's fund bought little more than 5 million shares, and Burry disclosed in 13F filings that he purchased call contracts against 350,000 shares of UnitedHealth. The holdings suggest Burry is betting on a sector turnaround, particularly as Medicare Advantage rates have exceeded expectations for 2026, and UnitedHealth's competitive positioning remains strong despite recent setbacks. Berkshire Hathaway's stake in UnitedHealth signals confidence but largely reinforces the consensus that earnings are currently depressed. Investors with a five-year horizon could benefit, though most still expect steady annual of America Securities (BofA) remains bullish, projecting earnings recovery by 2027, which could drive both upside in profits and valuation multiples. Analyst Kevin Fischbeck raised the price forecast from $290 to $325 on the better peer multiples, reaffirming the Neutral rating. For UnitedHealth, guidance is everything. The stock only works if the company delivers, particularly with upside on its medical loss ratio. BofA notes it's been over two years since a "United-type" quarter, but steady beats and raises could restore confidence in management and its grasp of healthcare trends. CMS will release 2027 Star Ratings in mid-October, determining how much UnitedHealth's Medicare Advantage business qualifies for the 5% quality bonus. With Medicare Advantage margins thin at 3–5%, ratings are a key driver of profitability. Recent drops at Humana Inc. (NYSE:HUM) and CVS Health Group Inc. (NYSE:CVS) underscore the risk. If UnitedHealth posts weaker scores, margin recovery could be pushed back to 2028, leaving it no better than peers. For UnitedHealth, the key focus is the 2027 Medicare Advantage (MA) rate update, due in February 2026. The 2026 update delivered the most significant increase in a decade, easing concerns about an unfriendly policy stance. The bigger risk lies in coding changes. With 2026 as the final year of the V28 phase-in, no extra cuts were applied, which improved sentiment. However, 2027 could pair a stronger rate update with a new coding adjustment (V29), potentially offsetting gains. Price Action: UNH stock is trading higher by 3.58% to $314.88 at last check Monday. Read Next:Photo by via Shutterstock Latest Ratings for UNH Date Firm Action From To Jan 2022 SVB Leerink Maintains Outperform Jan 2022 BMO Capital Maintains Market Perform Jan 2022 Raymond James Maintains Strong Buy View More Analyst Ratings for UNH View the Latest Analyst Ratings Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? UNITEDHEALTH GROUP (UNH): Free Stock Analysis Report This article Berkshire's UnitedHealth Bet Highlights Long-Term Confidence Despite Depressed Earnings originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store